ESCI收录;篇均引30.0,即时影响因子22.3(Web of Science);CiteScore 2023为17.2,CiteScoreTracker 2024为27.1,在Multidisciplinary中排名第9,跻身综合期刊世界前5%(Scopus);百引耗时平均5.9天,2025年将获得首个影响因子预计20! 点击卡片 关注我们 Front Cover Back Cover ...
of work (an average of 15 years) and a large investment. Exploration of Drug Science (EDS) was born with the idea of covering all the steps of this often magical process, from the discovery itself, the preclinical phase, to the clinical phase. As the new Editor-in-Chief of EDS, I ...
ESCI收录,CiteScore 17.2,在Multidisciplinary中排名第9,跻身综合期刊世界前5%,篇均引24.88(Web of Science),即时影响因子16.1,百引耗时平均5.9天,2025年将获得首个影响因子预计20 点击卡片 关注我们 Front Cover Back Cover Inside Front Cover Inside Back Cover 滑动...
Professor of Department of Chemistry, The University of Hong Kong, Hong Kong, China Research Keywords: synthetic protein; antibiotics; glycoconjugates; drug conjugates About the Special Issue Peptides have emerged as an exciting therapeutic modality with middle-sized molecular weights and pharmacological p...
coli gene-knockout mutants, we make de novo predictions of drug MoAs and systematically predict epistatic drug interactions. We show that high-throughput metabolic profiling of bacterial response to small molecules can expand the search for new antimicrobial treatments to compounds with no growth-...
1,主编梁兴杰研究员和执行主编师冰洋教授共同撰写的创刊词,对《Exploration》创刊意义、宗旨和愿景进行介绍,“Exploration: Explore a better future with advanced science and technology”; 2,河南大学宋纯鹏教授、澳大利亚科学院院士John Patrick教授与Tina Offler教授课题组合作撰写的前瞻评述, “From mouse to mouse-...
为加强学术交流与合作、促进期刊发展,我们特举办“2022Exploration-Life Science云论坛”,邀请Exploration生命科学方向青年编委、学术编辑及前沿科学研究领域有重要影响力的科学家做学术报告。论坛面向国际学术前沿、重大科学问题与技术难题,重...
Cancer is the greatest cause of mortality worldwide. Various drug classes treat various cancers. Nanoformulations made from natural sources are being studied for treating several diseases, including[...] Read more. Roshan Yadav ... Tejpal Yadav ...